Timothy S. Nelson, President and CEO, Director at MAP Pharmaceuticals, Inc. (MAPP), bought 10,000 shares at $2.17 ($22K) on 2009-03-05, disclosed to the SEC on 2009-03-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MAPP | SELL | 2011-12-22 | $290K | — | Filing → |
| MAPP | SELL | 2010-07-02 | $182K | — | Filing → |
| MAPP | SELL | 2010-06-03 | $432K | — | Filing → |